# Phase 4 Myocardial Infarction trials recruiting: 35 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 35 trials in phase 4 for Myocardial Infarction that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 4 Myocardial Infarction trials: 35 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-4/myocardial-infarction

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 35
- Recruiting or not yet: 35
- Read on: November 19, 2026

## Trials

The 25 newest of 35, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 16, 2026 | NCT07939516 | Individualized Genotype-guided Antiplatelet Therapy in Patients With Acute Coronary Syndrome | Medisch Spectrum Twente | Phase 4 | Not yet recruiting | Acute Coronary Syndromes (ACS), Unstable Angina Pectoris, Myocardial Infarction (MI), STEMI, NSTEMI | 3,120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939516) |
| October 15, 2026 | NCT07875179 | IMPROVE-STEMI: pPCI Plus Low-dose r-SK in STEMI | The Affiliated Hospital of Xuzhou Medical University | Phase 4 | Not yet recruiting | ST Elevation Myocardial Infarction (STEMI) | 3,300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07875179) |
| September 18, 2026 | NCT07828210 | NeuroAiD Patient-Reported Outcomes in Patients With Mild to Moderate Ischemic Stroke | EVD Pharmacy and Medical Company Limited | Phase 4 | Recruiting | Stroke, Stroke, Acute Ischemic, Stroke, Ischemic, Stroke, Cryptogenic, Stroke, Cardiovascular | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07828210) |
| September 17, 2026 | NCT07824323 | Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary Syndrome | Taipei Medical University Hospital | Phase 4 | Recruiting | Acute Coronary Syndromes, Dyslipidemia | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07824323) |
| August 31, 2026 | NCT07795398 | DAN-RELEASE - Reconsidering Long-Term Aspirin in the Elderly Patients With Stable Ischemic Heart Disease | Odense University Hospital | Phase 4 | Recruiting | Ischemic Heart Disease, Ischemic Heart Disease Chronic, Chronic Coronary Syndrome, Myocardial Infarction, Percutaneous... | 7,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07795398) |
| July 6, 2026 | NCT07684742 | Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome | Gyeongsang National University Hospital | Phase 4 | Recruiting | Acute Coronary Syndromes, STEMI, NSTEMI, Unstable Angina | 2,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07684742) |
| June 11, 2026 | NCT07641231 | Reperfusion Approach in Predicted In-hospital Delay for Primary PCI in STEMI | National Medical Research Center for Cardiology, Ministry of Health of Russian Federation | Phase 4 | Not yet recruiting | STEMI - ST Elevation Myocardial Infarction | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07641231) |
| June 1, 2026 | NCT07617376 | Pre-discharge Influenza Vaccination in Patients Hospitalized for Acute Cardiac Conditions | Wroclaw Medical University | Phase 4 | Recruiting | Myocardial Infarction, Decompensated Chronic Heart Failure, Acute Heart Failure (AHF), Pulmonary Embolism Acute... | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07617376) |
| April 24, 2026 | NCT07549282 | Intranasal Dexmedetomidine and Perioperative Myocardial Injury | Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 4 | Not yet recruiting | Coronary Heart Disease, Myocardial Injury, Myocardial Infarction, Dexmedetomidine | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07549282) |
| April 17, 2026 | NCT07536802 | Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention | National Institute of Cardiovascular Diseases, Pakistan | Phase 4 | Recruiting | ST-Segment Elevation Myocardial Infarction (STEMI), No-Reflow Phenomenon, Coronary Slow Flow, Acute Myocardial... | 1,148 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07536802) |
| April 6, 2026 | NCT07511257 | Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia | Instituto Nacional de Cardiologia Ignacio Chavez | Phase 4 | Recruiting | Coronary Artery Ectasia, Acute Coronary Syndromes (ACS), STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST... | 326 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07511257) |
| April 2, 2026 | NCT07507500 | Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 Months | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | Phase 4 | Recruiting | Myocardial Infarction (MI) | 8,100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07507500) |
| March 17, 2026 | NCT07476859 | Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome | Fundación para la Investigación del Hospital Clínico de Valencia | Phase 4 | Recruiting | Acute Coronary Syndromes (ACS), Iron Deficiencies, Elderly (People Aged 65 or More) | 538 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07476859) |
| December 18, 2025 | NCT07290699 | Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period | Second Affiliated Hospital of Nanchang University | Phase 4 | Not yet recruiting | STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI) | 2,442 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07290699) |
| October 2, 2025 | NCT07203846 | Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor | Collegium Medicum w Bydgoszczy | Phase 4 | Not yet recruiting | ACS - Acute Coronary Syndrome, Ticagrelor, Microbiota, Platelet Aggregation, Myocardial Infarction (MI), Blood... | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07203846) |
| September 29, 2025 | NCT07195812 | Rivaroxaban for Slow Coronary Flow After PCI in STEMI | Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 4 | Not yet recruiting | ST Elevation Myocardial Infarction, No-Reflow Phenomenon | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07195812) |
| June 5, 2025 | NCT07007143 | STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant | Chinese Academy of Medical Sciences, Fuwai Hospital | Phase 4 | Recruiting | Mitral Regurgitation | 1,032 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07007143) |
| March 30, 2025 | NCT06901466 | STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant | Chinese Academy of Medical Sciences, Fuwai Hospital | Phase 4 | Recruiting | Mitral Regurgitation | 880 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06901466) |
| January 22, 2025 | NCT06787430 | Effects of Nicorandil on Microvascular Dysfunction in Patients With STEMI Undergoing Primary PCI | China National Center for Cardiovascular Diseases | Phase 4 | Not yet recruiting | STEMI - ST-segment Elevation Myocardial Infarction | 170 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06787430) |
| January 10, 2025 | NCT06769256 | Intracoronary rhTNK-tPA Versus Tirofiban in Patients With STEMI and High Thrombus Burden | Henan Institute of Cardiovascular Epidemiology | Phase 4 | Recruiting | ST-segment Elevation Myocardial Infarction (STEMI) | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06769256) |
| January 3, 2025 | NCT06756945 | Low-dose Evaluation of Aspirin After STEMI Patients With PCI: A Multicenter, Double-blind, Randomized Controlled Clinical Trial | Beijing Anzhen Hospital | Phase 4 | Not yet recruiting | ST-elevation Myocardial Infarction (STEMI) | 3,612 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06756945) |
| August 20, 2024 | NCT06562582 | STunning in Acute Myocardial Infarction - BAS | Vastra Gotaland Region | Phase 4 | Recruiting | Myocardial Infarct | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06562582) |
| August 28, 2023 | NCT06013020 | Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus | Zunyi Medical College | Phase 4 | Recruiting | STEMI - ST Elevation Myocardial Infarction | 374 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06013020) |
| April 3, 2023 | NCT05794399 | Anticoagulation in Post MI LV Thrombus Trial in Nepal | Shahid Gangalal National Heart Centre | Phase 4 | Recruiting | Left Ventricular Thrombus, Myocardial Infarction | 196 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05794399) |
| March 8, 2023 | NCT05759078 | Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With... | Wroclaw Medical University | Phase 4 | Recruiting | Myocardial Infarction, Acute | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05759078) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| Chinese Academy of Medical Sciences, Fuwai Hospital | 2 |
| Wroclaw Medical University | 2 |
| EVD Pharmacy and Medical Company Limited | 1 |
| Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 1 |
| Beijing Anzhen Hospital | 1 |
| Penza State University | 1 |
| Collegium Medicum w Bydgoszczy | 1 |
| Henan Institute of Cardiovascular Epidemiology | 1 |
| Medisch Spectrum Twente | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| Research Maatschap Cardiologen Rotterdam Zuid | 1 |
| National Institute of Cardiovascular Diseases, Pakistan | 1 |
| Spanish Society of Cardiology | 1 |
| St. Antonius Hospital | 1 |
| Second Affiliated Hospital of Nanchang University | 1 |
| Instituto Nacional de Cardiologia Ignacio Chavez | 1 |
| National Medical Research Center for Cardiology, Ministry of Health of Russian Federation | 1 |
| Gyeongsang National University Hospital | 1 |
| Samsung Medical Center | 1 |
| The Affiliated Hospital of Xuzhou Medical University | 1 |
| Shahid Gangalal National Heart Centre | 1 |
| Vastra Gotaland Region | 1 |
| Odense University Hospital | 1 |
| The First Affiliated Hospital with Nanjing Medical University | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 7 |
| Poland | 4 |
| Netherlands | 4 |
| South Korea | 4 |
| Spain | 2 |
| Russia | 2 |
| Belgium | 2 |
| Denmark | 2 |
| Vietnam | 1 |
| Ireland | 1 |
| Latvia | 1 |
| Norway | 1 |
| Czechia | 1 |
| Germany | 1 |
| Italy | 1 |
| Serbia | 1 |
| Pakistan | 1 |
| Mexico | 1 |
| Nepal | 1 |
| Sweden | 1 |
| Taiwan | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Inns in the United States](https://specstream.ai/data/businesses/inns/united-states)
- [Suppliers and distributors in the United States](https://specstream.ai/data/businesses/suppliers-and-distributors/united-states)
- [Contractors in the United States](https://specstream.ai/data/businesses/contractors/united-states)
- [Metal plating companies in the United States](https://specstream.ai/data/businesses/metal-plating-companies/united-states)
- [Wholesale florists in the United States](https://specstream.ai/data/businesses/wholesale-florists/united-states)
- [European restaurants in the United States](https://specstream.ai/data/businesses/european-restaurants/united-states)
